UPDATE: Wells Fargo Starts Rapt Therapeutics (RAPT) at Outperformon Opportunities for CCR4 Inhibitor Program
Tweet Send to a Friend
(Updated - November 25, 2019 5:16 AM EST)
(update comment, analyst name)Wells Fargo analyst Yanan Zhu initiates coverage on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(update comment, analyst name)Wells Fargo analyst Yanan Zhu initiates coverage on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
